FindTrial
Sign In

To Compare The Effect Of Methotrexate Versus Oral Mini Pulse(Betamethasone) With Narrow Band Ultra Violet-B In The Patients Of Vitiligo Vulagris.

A Randomized Controlled Study To Compare The Effect Of Methotrexate Versus Oral Mini Pulse(Betamethasone) With Narrow Band Ultra Violet-B In The Patients Of Vitiligo Vulagris.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009473
Enrollment
140
Registered
2017-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with vitiligo vulgaris

Interventions

Intervention1: RCT TO Compare The Effect Of Methotrexate Versus Oral Mini Pulse(Betamethasone) With Narrow Band Ultra Violet-B In The Patients Of Vitiligo Vulagris.: GROUP A : MTX 7.5 mg Once a we

Sponsors

Mahatma Gandhi Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All clinically confirmed Vitiligo Vulgaris Cases.

Exclusion criteria

Exclusion criteria: 1. The Patients with Pre-existing Leucopenia ( 2. thrombocytopenia ( 3. significant anemia (Hb 4. Pregnant and breast feeding women. 5. Patients with Diabetes Mellitus -Patients with active severe infections and immunodeficiency such as HIV, TB. -Patients who are prone to develop photosensitivity reactions.

Design outcomes

Primary

MeasureTime frame
Repigmentation Extent of the disease Spreading of the diseaseTimepoint: November 2017—

Secondary

MeasureTime frame
Assessing Side Effects of the Drugs UsedTimepoint: In every three months.—

Countries

India

Contacts

Public ContactDR GARIMA KHURANA

MGM MEDICAL COLLEGE AND HOSPITAL, AURANGABAD

ashish7557@gmail.com8390151617

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026